Dr Ivan Cohen, MD | |
262 Chapman Rd, Bellevue Bldg. Suite 100, Newark, DE 19702-5448 | |
(302) 292-0888 | |
(303) 292-0889 |
Full Name | Dr Ivan Cohen |
---|---|
Gender | Male |
Speciality | Psychiatry |
Experience | 54 Years |
Location | 262 Chapman Rd, Newark, Delaware |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588676365 | NPI | - | NPPES |
C10004287 | Medicaid | DE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0802X | Psychiatry & Neurology - Addiction Psychiatry | C10004287 (Delaware) | Primary |
2084P0800X | Psychiatry & Neurology - Psychiatry | C10004287 (Delaware) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dean A Aman, Lpcmh, Llc | 0244452712 | 3 |
News Archive
A report from the Government Accountability Office (GAO) issued Monday finds that "[p]rices on a growing number of prescription medications have ballooned in recent years as consolidation in the drug industry leaves fewer companies manufacturing niche medications," The Associated Press reports.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
Prurigo nodularis (PN) is a chronic skin disease that affects an estimated 72 out of 100,000 people in the U.S. The disease disproportionately affects Black patients and other minority groups.
Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc., today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC).
› Verified 4 days ago
Entity Name | Dean A Aman, Lpcmh, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124429055 PECOS PAC ID: 0244452712 Enrollment ID: O20141118001009 |
News Archive
A report from the Government Accountability Office (GAO) issued Monday finds that "[p]rices on a growing number of prescription medications have ballooned in recent years as consolidation in the drug industry leaves fewer companies manufacturing niche medications," The Associated Press reports.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
Prurigo nodularis (PN) is a chronic skin disease that affects an estimated 72 out of 100,000 people in the U.S. The disease disproportionately affects Black patients and other minority groups.
Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc., today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC).
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Ivan Cohen, MD 262 Chapman Rd, Bellevue Bldg. Suite 100, Newark, DE 19702-5448 Ph: (302) 292-0888 | Dr Ivan Cohen, MD 262 Chapman Rd, Bellevue Bldg. Suite 100, Newark, DE 19702-5448 Ph: (302) 292-0888 |
News Archive
A report from the Government Accountability Office (GAO) issued Monday finds that "[p]rices on a growing number of prescription medications have ballooned in recent years as consolidation in the drug industry leaves fewer companies manufacturing niche medications," The Associated Press reports.
Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.
Prurigo nodularis (PN) is a chronic skin disease that affects an estimated 72 out of 100,000 people in the U.S. The disease disproportionately affects Black patients and other minority groups.
Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc., today announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone) 24 microgram (mcg) gel capsules for the long-term treatment of patients with chronic idiopathic constipation (CIC).
› Verified 4 days ago
Jonathan M Raser-schramm, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 774 Christiana Rd, Suite 201, Newark, DE 19713 Phone: 302-731-3017 Fax: 302-733-1888 | |
Dr. Ayesha Silman, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 100 Rockford Dr, Newark, DE 19713 Phone: 302-996-5480 | |
Yawar Abbas, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Rockford Center, 100 Rockford Dr, Newark, DE 19713 Phone: 302-996-5480 | |
Dr. Panna Kalyanji Jolapara, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 18 Capano Drive, Apt C4, Newark, DE 19702 Phone: 302-292-8693 Fax: 302-292-8693 | |
Enrica Arnaudo, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 774 Christiana Rd, Suite 201, Newark, DE 19713 Phone: 302-731-3017 Fax: 302-266-9960 | |
Stephen Doyle, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4755 Ogletown Stanton Rd, Newark, DE 19718 Phone: 302-733-1000 | |
Lanny Edelsohn, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 774 Christiana Rd, Suite 201, Newark, DE 19713 Phone: 302-731-3017 Fax: 302-266-9960 |